1. Home
  2. Live Updates
  3. Harma stocks

Live Breaking News & Updates on Harma stocks

Stay informed with the latest breaking news from Harma stocks on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Harma stocks and stay connected to the pulse of your community

Medicamen Biotech shares zoom 20%, up 40% in two sessions

Despite a decent recovery from its 52-week low, Medicamen Biotech is still 35 percent away from its 52-week high

United-states , Haridwar , Uttaranchal , India , Shivalik-rasayan , Drug-administration , Medicamen-biotech , United-states-food , Medicamen-biotech-shares , Hares-of-medicamen-biotech , Harma-stocks , Uzzing-stocks

Piramal Pharma falls 5% after FDA lists 3 observations on US facility

Piramal Pharma reassured stakeholders that the observations were classified under the Voluntary Action Indicated (VAI) category and did not involve issues related to data integrity

Mumbai , Maharashtra , India , Piramal-pharma , Drug-administration , Piramal-pharma-limited , Voluntary-action-indicated , Da , Bservations , Harma-stocks , Tock-market-news ,

Madhu Kela's top three bets: PSU banks, pharma, tourism stocks

Madhusudan Kela believes that the tourism sector has tremendous potential, specifically religious tourism

Ayodhya , Uttar-pradesh , India , Canara , Karnataka , Ujjain , Madhya-pradesh , Madhusudan-kela , Nirmala-sitharaman , Vaishno-devi , Punjab-sind-bank , Canara-bank

MC Pro Quick Take: Sun Pharma's US sales outpace Dr Reddy's, Cipla in Q3

Sun Pharma’s specialty drugs business continue to grow at a brisk pace, helped by ramp-up of key products

Sun-pharma , Cipla , Sun-pharmaceutical-industries , Quick-take , R-reddys-labs , Ipla , 3-fy24 , S-sales , Harma-stocks , Rice-erosion , Arnings , Evenues

Watch: From gender inclusion, role models to 70-hour work week, pay parity and more, Nandini Piramal, Falguni Nayar, Zia Mody, Kalpana Morparia share insights at BT MPW 2023

BT MPW 2023: From gender inclusion, role models to 70-hour work week, pay parity and much more, watch Nandini Piramal, Falguni Nayar, Zia Mody, Kalpana Morparia as they share insights.

Nandan-nilekani , Nandini-piramal , Infosys , Business-today , Harma , Nfosys , Arayana-murthy , Alguni-nayar , Ykaa , Iramal , Adhabi-puri-buch , Ebi

Cipla's arm InvaGen Pharma USA recalls anti-epileptic drug due to packaging issues

The product is used for the treatment of refractory complex partial seizures as adjunctive therapy in patients 2 years of age and older

Indore , Madhya-pradesh , India , Cooper-pharma , Cipla , Invagen-pharmaceuticals , Invagen-pharmaceuticals-united-states , Oral-solution , Gen-pharmaceuticals , Watch-adverse-event-reporting , Nifty-pharma , Nvagen-pharma-usa

Indian Stocks Slide As IT Declines On Last Trading Session Pharma Rebounds - BW Businessworld

Nifty 50 index concluded 0.04 per cent lower at 19,794, while the Sensex closed with 0.07 per cent loss at 65,970, , stock market, nifty, sensex, it stocks, pharma stocks, retail investors, Intraday, national stock exchange, Honasa Consumer, life insurance, defence stocks

Hindustan , India-general- , India , Bombay , Maharashtra , Bharat , Prashanth-tapse , Senior-vp-research , Adani-enterprises , Nifty-realty , Mm-financial-services , Divis-lab

Cipla tanks almost 7% as USFDA's letter flags data issues at Madhya Pradesh unit

According to a CNBC-TV18, the warning letter has underlined data integrity issues at Cipla embedded with product complaints and microbial contamination

Indore , Madhya-pradesh , India , United-states , Prabhudas-lilladher , Umang-vohra , Cipla , National-stock-exchange , United-states-food , Ipla-stock-price , Sfda , Ithampur-facility

Natco Pharma trades 2% lower even as its Q2 net profit zooms 550% YoY

The Natco Pharma stock has given a return of 26.22 percent over the last six months. The benchmark Nifty50 index has given a return of 5.68 percent over the same duration.

Natco-pharmadropped , Natco-pharma , Natco-pharma-ltd-on , Natco-pharma-ltd , Pharma-ltd , Natco-pharma-consolidated-september , Institutional-investors , Foreign-institutional-investors , Atco-pharma-q2 , Atco-pharma-stock-in-news , Uzzing-stocks , Harma-stocks

Recent selloff no cause for worry; look for sectors that have the potential to beat the index, says this wealth manager

The recent market correction is not substantive enough for investors to fret over. IT, Pharma & capital goods hold promise, says Feroze Azeez, Deputy CEO at Anand Rathi Wealth.

Israel , Gaza , Israel-general- , Feroze-azeez , Anand-rathi-wealth , Bse-capital-goods , T-stocks , Etal-stocks , Harma-stocks ,